Evidence map›Paper›PMID 38776321›Full record

ArticlePLoS pathogens2024

Dampening of ISGylation of RIG-I by ADAP regulates type I interferon response of macrophages to RNA virus infection.

Yan Wang, Haixia Feng, Xiao Li, Yina Ruan, Yueping Guo, Xinxing Cui, Pengchao Zhang, Yanli Li, Xinning Wang, Xingran Wang and 5 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. ISGylation: is our genome yearning for such a modification?Acta biochimica et biophysica Sinica · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yan WangInstitutes of Biology and Medical Sciences (IBMS), Soochow University, Suzhou, Jiangsu Province, China.
Haixia FengInstitutes of Biology and Medical Sciences (IBMS), Soochow University, Suzhou, Jiangsu Province, China.
Xiao LiInstitutes of Biology and Medical Sciences (IBMS), Soochow University, Suzhou, Jiangsu Province, China.
Yina RuanChildren's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
Yueping GuoDepartment of Veterinary Medicine, Zhejiang A&F University, Hangzhou, Zhejiang Province, China.
Xinxing CuiInstitutes of Biology and Medical Sciences (IBMS), Soochow University, Suzhou, Jiangsu Province, China.
Pengchao ZhangInstitutes of Biology and Medical Sciences (IBMS), Soochow University, Suzhou, Jiangsu Province, China.
Yanli LiInstitutes of Biology and Medical Sciences (IBMS), Soochow University, Suzhou, Jiangsu Province, China.
Xinning WangInstitutes of Biology and Medical Sciences (IBMS), Soochow University, Suzhou, Jiangsu Province, China.
Xingran WangInstitutes of Biology and Medical Sciences (IBMS), Soochow University, Suzhou, Jiangsu Province, China.
Luxin WeiDepartment of General Surgery, The Fourth Affiliated Hospital of Soochow University, Suzhou, China.
Yulan YiDepartment of Biological Sciences, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu Province, China.
Lifeng ZhangDepartment of General Surgery, The Fourth Affiliated Hospital of Soochow University, Suzhou, China.
Xiaodong YangDepartment of Gastrointestinal Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Hebin LiuInstitutes of Biology and Medical Sciences (IBMS), Soochow University, Suzhou, Jiangsu Province, China.ORCID 0000-0003-3690-6018

Funding

National Natural Science Foundation of China (NSFC) 31470840Natural Science Foundation of Jiangsu Higher Education Institution-Key Program 21KJA310002Soochow University Research Development Funds Q424900220Suzhou Key Program Special Funds KSF-A-21
6 · The paper itself

Abstract

While macrophage is one of the major type I interferon (IFN-I) producers in multiple tissues during viral infections, it also serves as an important target cell for many RNA viruses. However, the regulatory mechanism for the IFN-I response of macrophages to respond to a viral challenge is not fully understood. Here we report ADAP, an immune adaptor protein, is indispensable for the induction of the IFN-I response of macrophages to RNA virus infections via an inhibition of the conjugation of ubiquitin-like ISG15 (ISGylation) to RIG-I. Loss of ADAP increases RNA virus replication in macrophages, accompanied with a decrease in LPS-induced IFN-β and ISG15 mRNA expression and an impairment in the RNA virus-induced phosphorylation of IRF3 and TBK1. Moreover, using Adap-/- mice, we show ADAP deficiency strongly increases the susceptibility of macrophages to RNA-virus infection in vivo. Mechanically, ADAP selectively interacts and functionally cooperates with RIG-I but not MDA5 in the activation of IFN-β transcription. Loss of ADAP results in an enhancement of ISGylation of RIG-I, whereas overexpression of ADAP exhibits the opposite effect in vitro, indicating ADAP is detrimental to the RNA virus-induced ISGylation of RIG-I. Together, our data demonstrate a novel antagonistic activity of ADAP in the cell-intrinsic control of RIG-I ISGylation, which is indispensable for initiating and sustaining the IFN-I response of macrophages to RNA virus infections and replication.

Indexed as

Adaptor Proteins, Signal TransducingDEAD Box Protein 58Interferon Type IMacrophagesMice, KnockoutRNA Virus InfectionsUbiquitinsAnimalsCytokinesHumansInterferon-betaInterferon Regulatory Factor-3MiceMice, Inbred C57BLReceptors, ImmunologicRNA VirusesAdaptor Proteins, Signal TransducingCytokinesDdx58 protein, mouseDEAD Box Protein 58G1p2 protein, mouseInterferon-betaInterferon Regulatory Factor-3Interferon Type IReceptors, ImmunologicUbiquitins

Identifiers

PMID38776321
PMCPMC11111093

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.